Answers are grounded in this paper and cite their sources.
Background and Aims Quantification of the soft tissue uptake in 99m Tc‐DPD has emerged as a promising imaging biomarker in ATTRwt. Recent findings suggest a potential role of [ 99m Tc]Tc‐DPD soft tissue uptake in the diagnosis of polyneuropathy in these patients. Methods In this registry study, we analyzed all patients who presented at the Amyloidosis Centre Berlin and underwent a standardized diagnostic protocol comprising a multidisciplinary examination, neuroelectrophysiology, ECG, biomarkers, [ 99m Tc]Tc‐DPD scintigraphy and echocardiography, without other causes of polyneuropathy. We analyzed the planar scans using soft‐tissue‐to‐bone and heart‐to‐hemithorax ratios. We assessed the subcutaneous fat uptake using derived from SPECT/CT. Results Of the 72 patients, 57 ATTRwt patients were included in the analysis. Among these, the prevalence of polyneuropathy and cardiomyopathy was 60% and 95%, respectively. The neurographic pattern was mainly axonal (53%) or mixed (32%). Patients with polyneuropathy showed significantly higher in axillary subcutaneous tissue compared to those without ( p ‐value = 0.002). There was no correlation between extracardiac tracer uptake and polyneuropathy severity by using the NIS. Interpretation Our results indicate that amyloid load in soft tissue may serve as a potential indicator of peripheral neurological involvement. Future studies are required to explore the utility of DPD scintigraphy for outcome assessment in treated patients.
No takes yet. Share an insight, caveat, or question.
Asaad et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: